HK1178888A1 - Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring - Google Patents
Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ringInfo
- Publication number
- HK1178888A1 HK1178888A1 HK13105594.4A HK13105594A HK1178888A1 HK 1178888 A1 HK1178888 A1 HK 1178888A1 HK 13105594 A HK13105594 A HK 13105594A HK 1178888 A1 HK1178888 A1 HK 1178888A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- carboxylic acid
- acid derivatives
- heterocyclic carboxylic
- oxazolopyrimidine ring
- substituted oxazolopyrimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10305037 | 2010-01-13 | ||
PCT/EP2011/050299 WO2011086078A1 (fr) | 2010-01-13 | 2011-01-12 | Dérivés d'acide carboxylique hétérocyclique comprenant un noyau d'oxazolopyrimidine à substitution en 2,5,7 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1178888A1 true HK1178888A1 (en) | 2013-09-19 |
Family
ID=41820658
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK13105594.4A HK1178888A1 (en) | 2010-01-13 | 2013-05-10 | Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
Country Status (21)
Country | Link |
---|---|
US (1) | US8846691B2 (fr) |
EP (1) | EP2523959B1 (fr) |
JP (1) | JP5844278B2 (fr) |
KR (1) | KR101759121B1 (fr) |
CN (1) | CN102906098B (fr) |
AR (1) | AR079982A1 (fr) |
AU (1) | AU2011206614B8 (fr) |
BR (1) | BR112012017240A2 (fr) |
CA (1) | CA2792134C (fr) |
DK (1) | DK2523959T3 (fr) |
ES (1) | ES2449705T3 (fr) |
HK (1) | HK1178888A1 (fr) |
IL (1) | IL220708A (fr) |
MX (1) | MX2012007833A (fr) |
MY (1) | MY156551A (fr) |
PT (1) | PT2523959E (fr) |
RU (1) | RU2554869C2 (fr) |
SG (1) | SG182473A1 (fr) |
TW (1) | TWI517851B (fr) |
UY (1) | UY33178A (fr) |
WO (1) | WO2011086078A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI485153B (zh) | 2010-01-13 | 2015-05-21 | Sanofi Aventis | 2,5,7-經取代唑并嘧啶衍生物 |
AU2011206615B2 (en) * | 2010-01-14 | 2015-03-19 | Sanofi | Carboxylic acid derivatives having A 2,5-substituted oxazolopyrimidine ring |
CN102834399B (zh) * | 2010-01-14 | 2015-04-22 | 赛诺菲 | 具有2,5-取代的*唑并嘧啶环的杂环羧酸衍生物 |
MY159857A (en) | 2010-01-14 | 2017-02-15 | Sanofi Sa | 2,5-substituted oxazolopyrimidine derivatives |
US9321787B2 (en) | 2011-07-07 | 2016-04-26 | Sanofi | Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3679682A (en) * | 1970-04-23 | 1972-07-25 | Fmc Corp | CERTAIN 5H-ISOXAZOLO{8 5,4-d{9 PYRIMIDIN-4-ONES |
PE20050158A1 (es) * | 2003-05-19 | 2005-05-12 | Irm Llc | Compuestos inmunosupresores y composiciones |
US7060697B2 (en) * | 2003-05-19 | 2006-06-13 | Irm Llc | Immunosuppressant compounds and compositions |
US7855193B2 (en) * | 2005-11-23 | 2010-12-21 | Epix Pharmaceuticals, Inc. | S1P receptor modulating compounds and use thereof |
WO2007109334A2 (fr) * | 2006-03-21 | 2007-09-27 | Epix Delaware, Inc. | Composés modulant les récepteurs de la s1p et leur utilisation |
TW201000099A (en) * | 2008-06-20 | 2010-01-01 | Amgen Inc | S1P1 receptor agonists and use thereof |
-
2011
- 2011-01-11 TW TW100100891A patent/TWI517851B/zh not_active IP Right Cessation
- 2011-01-11 UY UY0001033178A patent/UY33178A/es not_active Application Discontinuation
- 2011-01-11 AR ARP110100075A patent/AR079982A1/es unknown
- 2011-01-12 CA CA2792134A patent/CA2792134C/fr not_active Expired - Fee Related
- 2011-01-12 AU AU2011206614A patent/AU2011206614B8/en not_active Ceased
- 2011-01-12 BR BR112012017240A patent/BR112012017240A2/pt not_active IP Right Cessation
- 2011-01-12 ES ES11700136.2T patent/ES2449705T3/es active Active
- 2011-01-12 EP EP11700136.2A patent/EP2523959B1/fr active Active
- 2011-01-12 KR KR1020127021141A patent/KR101759121B1/ko active IP Right Grant
- 2011-01-12 WO PCT/EP2011/050299 patent/WO2011086078A1/fr active Application Filing
- 2011-01-12 RU RU2012134463/04A patent/RU2554869C2/ru not_active IP Right Cessation
- 2011-01-12 PT PT117001362T patent/PT2523959E/pt unknown
- 2011-01-12 US US13/521,829 patent/US8846691B2/en active Active
- 2011-01-12 DK DK11700136.2T patent/DK2523959T3/en active
- 2011-01-12 CN CN201180013919.9A patent/CN102906098B/zh active Active
- 2011-01-12 SG SG2012051165A patent/SG182473A1/en unknown
- 2011-01-12 MY MYPI2012002589A patent/MY156551A/en unknown
- 2011-01-12 MX MX2012007833A patent/MX2012007833A/es active IP Right Grant
- 2011-01-12 JP JP2012548409A patent/JP5844278B2/ja active Active
-
2012
- 2012-07-01 IL IL220708A patent/IL220708A/en not_active IP Right Cessation
-
2013
- 2013-05-10 HK HK13105594.4A patent/HK1178888A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20120101593A (ko) | 2012-09-13 |
TW201134472A (en) | 2011-10-16 |
ES2449705T3 (es) | 2014-03-20 |
AR079982A1 (es) | 2012-03-07 |
AU2011206614A1 (en) | 2012-08-02 |
PT2523959E (pt) | 2014-03-10 |
CN102906098B (zh) | 2015-07-15 |
UY33178A (es) | 2011-08-31 |
JP5844278B2 (ja) | 2016-01-13 |
AU2011206614B2 (en) | 2015-02-26 |
CA2792134C (fr) | 2017-12-05 |
EP2523959A1 (fr) | 2012-11-21 |
RU2012134463A (ru) | 2014-02-20 |
CN102906098A (zh) | 2013-01-30 |
KR101759121B1 (ko) | 2017-07-18 |
MY156551A (en) | 2016-02-26 |
AU2011206614B8 (en) | 2015-03-05 |
MX2012007833A (es) | 2012-07-20 |
TWI517851B (zh) | 2016-01-21 |
WO2011086078A1 (fr) | 2011-07-21 |
SG182473A1 (en) | 2012-08-30 |
CA2792134A1 (fr) | 2011-07-21 |
US20130158051A1 (en) | 2013-06-20 |
RU2554869C2 (ru) | 2015-06-27 |
IL220708A (en) | 2015-02-26 |
EP2523959B1 (fr) | 2013-11-27 |
BR112012017240A2 (pt) | 2016-03-22 |
US8846691B2 (en) | 2014-09-30 |
DK2523959T3 (en) | 2014-03-10 |
JP2013517240A (ja) | 2013-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201206440B (en) | [5,6]heterocyclic compound | |
EP2594566A4 (fr) | Dérivé de cycle hétérocyclique aromatique azoté | |
HK1187606A1 (zh) | 取代的 -稠合含氮雜環化合物及其用途 | |
IL214568A0 (en) | Hetero ring derivative | |
ZA201205788B (en) | 1,2,4-triazine-4-amine derivatives | |
IL225770A0 (en) | Heterocyclic compounds | |
IL221442A0 (en) | Heterocyclic compound | |
ZA201300950B (en) | Heterocyclic compound | |
EP2399914A4 (fr) | Composé à noyau hétérocyclique fusionné | |
AP3589A (en) | A novel 1,2,3,4-tetrahydroquinoline derivative useful for the treatment of diabetes | |
ZA201206630B (en) | Hetaryl-[1,8]naphthyridine derivatives | |
EP2399918A4 (fr) | Composé cyclique | |
IL220707A0 (en) | 2,5,7-substituted oxazolopyrimidine derivatives | |
HK1180314A1 (en) | Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring 257- | |
HK1178886A1 (en) | Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring | |
HK1178885A1 (en) | Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring | |
HK1178888A1 (en) | Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring | |
EP2583965A4 (fr) | Composé hétérocyclique | |
EP2632255A4 (fr) | Dérivés hétérocycliques de diazéniumdiolate | |
HUE050886T2 (hu) | 8-hidroxi-kinolin származékok | |
ZA201204349B (en) | New secondary 8-hydroxyquinoline 7-carboxamide derivatives | |
GB201021416D0 (en) | Novel heterocyclic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20190107 |